NASDAQ:TKNO Alpha Teknova (TKNO) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free TKNO Stock Alerts $1.88 +0.14 (+8.05%) (As of 11:03 AM ET) Add Compare Share Share Today's Range$1.81▼$1.8950-Day Range$1.70▼$3.0252-Week Range$1.66▼$4.27Volume3,229 shsAverage Volume13,561 shsMarket Capitalization$76.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Alpha Teknova alerts: Email Address Alpha Teknova MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish0.50% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.54Based on 9 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.66) to ($0.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.41 out of 5 starsMedical Sector2646th out of 2,771 stocksDiagnostic Substances Industry37th out of 39 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Alpha Teknova.Read more about Alpha Teknova's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted0.50% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Alpha Teknova has recently increased by 9.47%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlpha Teknova does not currently pay a dividend.Dividend GrowthAlpha Teknova does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TKNO. Previous Next 2.5 News and Social Media Coverage News SentimentAlpha Teknova has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Alpha Teknova this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Alpha Teknova to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alpha Teknova insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Alpha Teknova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 13.81% of the stock of Alpha Teknova is held by institutions.Read more about Alpha Teknova's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Alpha Teknova are expected to grow in the coming year, from ($0.66) to ($0.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Teknova is -1.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Teknova is -1.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Teknova has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Alpha Teknova's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyAmerica could fall from this eventAmerica’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About Alpha Teknova Stock (NASDAQ:TKNO)Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.Read More TKNO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TKNO Stock News HeadlinesMay 14 at 3:35 AM | markets.businessinsider.comBuy Rating Affirmed for Alpha Teknova Amid Strong Q1 Performance and Strategic Cost ReductionsMay 13 at 9:30 PM | investorplace.comTKNO Stock Earnings: Alpha Teknova Beats EPS, Beats Revenue for Q1 2024May 13 at 4:01 PM | globenewswire.comTeknova Reports First Quarter 2024 Financial ResultsMay 11 at 1:20 AM | americanbankingnews.comAlpha Teknova (TKNO) Set to Announce Quarterly Earnings on MondayMay 7, 2024 | globenewswire.comTeknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy DevelopmentApril 29, 2024 | globenewswire.comTeknova to Report First Quarter 2024 Financial Results on May 13, 2024March 13, 2024 | finance.yahoo.comAlpha Teknova, Inc. (NASDAQ:TKNO) Q4 2023 Earnings Call TranscriptMarch 13, 2024 | markets.businessinsider.comBuy Rating on Alpha Teknova Reinforced by Strong Management and Conservative Growth OutlookMarch 12, 2024 | finanznachrichten.deAlpha Teknova, Inc.: Teknova Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 11, 2024 | benzinga.comRecap: Alpha Teknova Q4 EarningsMarch 11, 2024 | finance.yahoo.comAlpha Teknova Inc (TKNO) Faces Revenue Decline Amid Market ChallengesMarch 11, 2024 | globenewswire.comTeknova Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 8, 2024 | benzinga.comEarnings Preview: Alpha TeknovaFebruary 21, 2024 | finance.yahoo.comTeknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024February 21, 2024 | globenewswire.comTeknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024February 9, 2024 | benzinga.comTelegraph Hill Partners IV Investment Management LLC's Net WorthDecember 23, 2023 | finance.yahoo.comAlpha Teknova Insiders Land Bargain With Gains Of US$1.4mNovember 16, 2023 | finance.yahoo.comAlpha Teknova (TKNO) Posted Better Than Expected Results in Q3November 12, 2023 | finance.yahoo.comAlpha Teknova, Inc. (NASDAQ:TKNO) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | benzinga.comAlpha Teknova: Q3 Earnings InsightsNovember 1, 2023 | morningstar.comAlpha Teknova Inc TKNOOctober 26, 2023 | finance.yahoo.comTeknova to Report Third Quarter 2023 Financial Results on November 9, 2023October 25, 2023 | msn.comAlpha Teknova files to sell 11.30M shares for holdersSeptember 27, 2023 | finance.yahoo.comTeknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process DevelopmentSeptember 27, 2023 | finance.yahoo.comTeknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process DevelopmentSee More Headlines Receive TKNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/11/2024Today5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:TKNO CUSIPN/A CIK1850902 Webwww.teknova.com Phone831-637-1100FaxN/AEmployees210Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,780,000.00 Net Margins-100.26% Pretax Margin-101.07% Return on Equity-38.12% Return on Assets-25.95% Debt Debt-to-Equity Ratio0.15 Current Ratio5.14 Quick Ratio3.84 Sales & Book Value Annual Sales$36.68 million Price / Sales1.94 Cash FlowN/A Price / Cash FlowN/A Book Value$2.21 per share Price / Book0.79Miscellaneous Outstanding Shares40,820,000Free Float34,618,000Market Cap$71.03 million OptionableNot Optionable Beta0.39 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Stephen Gunstream (Age 44)President, CEO & Director Comp: $937.79kMr. Matthew C. Lowell (Age 53)Chief Financial Officer Comp: $593.78kMr. Damon A. Terrill (Age 53)General Counsel, Chief Compliance Officer & Secretary Comp: $215.78kMs. Jennifer HenrySenior Vice President of MarketingKey CompetitorsVolitionRxNYSE:VNRXARCA biopharmaNASDAQ:ABIOImmuCellNASDAQ:ICCCCo-DiagnosticsNASDAQ:CODXAspira Women's HealthNASDAQ:AWHView All CompetitorsInsiders & InstitutionsPlatinum Investment Management Ltd.Sold 8,779 shares on 5/14/2024Ownership: 1.783%State Board of Administration of Florida Retirement SystemBought 13,310 shares on 5/9/2024Ownership: 0.033%Platinum Investment Management Ltd.Sold 97,989 shares on 2/14/2024Ownership: 2.503%Ken GelhausBought 3,587 shares on 11/30/2023Total: $6,205.51 ($1.73/share)Telegraph Hill Partners Iv, L.Bought 6,917,837 shares on 9/19/2023Total: $12.80 M ($1.85/share)View All Insider TransactionsView All Institutional Transactions TKNO Stock Analysis - Frequently Asked Questions Should I buy or sell Alpha Teknova stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alpha Teknova in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TKNO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TKNO, but not buy additional shares or sell existing shares. View TKNO analyst ratings or view top-rated stocks. How have TKNO shares performed in 2024? Alpha Teknova's stock was trading at $3.73 at the beginning of the year. Since then, TKNO stock has decreased by 53.4% and is now trading at $1.74. View the best growth stocks for 2024 here. When is Alpha Teknova's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our TKNO earnings forecast. How were Alpha Teknova's earnings last quarter? Alpha Teknova, Inc. (NASDAQ:TKNO) posted its quarterly earnings results on Monday, March, 11th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $7.87 million for the quarter, compared to analyst estimates of $8.20 million. Alpha Teknova had a negative trailing twelve-month return on equity of 38.12% and a negative net margin of 100.26%. What guidance has Alpha Teknova issued on next quarter's earnings? Alpha Teknova issued an update on its FY 2024 earnings guidance on Monday, May, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $35.0 million-$38.0 million, compared to the consensus revenue estimate of $38.1 million. When did Alpha Teknova IPO? Alpha Teknova (TKNO) raised $90 million in an initial public offering on Friday, June 25th 2021. The company issued 6,000,000 shares at $14.00-$16.00 per share. Who are Alpha Teknova's major shareholders? Alpha Teknova's stock is owned by a number of institutional and retail investors. Top institutional investors include Platinum Investment Management Ltd. (1.78%) and State Board of Administration of Florida Retirement System (0.03%). Insiders that own company stock include Damon Terrill, J Matthew Mackowski, Ken Gelhaus, Lisa Hood, Matthew Lowell, Stephen Gunstream, Ted Davis and Telegraph Hill Partners Iv, L. View institutional ownership trends. How do I buy shares of Alpha Teknova? Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TKNO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
